Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for IMMU stock. Download IMMU report.
Research Report
Get the full report for FREE
Date:Aug 12, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download IMMU report
  
Example preview: Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU)
   

News for Immunomedics, Inc (IMMU)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
News ·  Blogs ·  Filings
Symbol:  | Recent Quotes powered by
  quotemedia.com
News for Immunomedics Inc.  (IMMU) 
|
$ 3.55   0.10 (+2.90%) Volume: 879.65 k 4:00 PM EST Nov 20, 2009
After Hours:  $ 3.5599   0.0099 (+0.28%) Volume: 13.59 k 4:48 PM EST Nov 20, 2009
Thu, Nov 19, 2009
6:58 AM Complimentary Research Report on PETM, IMMU, RINO, AMSC, EXPE and BNVI by WallStSense.com - Marketwire
Fri, Nov 06, 2009
8:33 AM Immunomedics Announces First Quarter Fiscal 2010 Results and Clinical Program Developments - GlobeNewswire
Thu, Oct 29, 2009
6:12 AM TheFortuneFinancial.com Free Market Research on AMKR, EXPE, IMMU, BNVI, UCBH and FLIR - Marketwire
Tue, Oct 27, 2009
8:33 AM Immunomedics to Present at Upcoming Conferences - GlobeNewswire
Fri, Oct 23, 2009
8:30 AM Immunomedics Receives Corporate Award From New Jersey Inventors Hall of Fame - GlobeNewswire
Thu, Oct 22, 2009
10:55 AM Dr. Stockpick Announces Daily Stock Watch - IMMU, TRV, BK - World Stock Wire
Tue, Oct 20, 2009
7:25 AM RothmanResearch.com Stock Review for DTV, IMMU, FLIR, GILD, RINO and DSCO - Marketwire
Mon, Oct 19, 2009
8:30 AM Immunomedics Awarded Three Grants by NIH to Develop New Agents for Imaging and Therapy of Cancer - GlobeNewswire
Thu, Oct 15, 2009
9:31 AM Further Topline Results for Epratuzumab Phase IIb Study in Systemic Lupus Erythematosus (SLE) - GlobeNewswire
Tue, Sep 15, 2009
8:32 AM Immunomedics to Present At 2009 UBS Global Life Sciences Conference - GlobeNewswire
Fri, Sep 11, 2009
7:43 AM UCB and Immunomedics announce positive results for epratuzumab phase IIb study in systemic lupus erythematosus (SLE) - Hugin
Fri, Aug 28, 2009
8:00 AM ParagonReport.com Complimentary Analyst Research for American International Group, Inc. (NYSE: AIG), Dell Inc. (NASDAQ: DELL), Oshkosh Corporation (NYSE: OSK) and Immunomedics Inc. (NASDAQ: IMMU) - Marketwire
Thu, Aug 27, 2009
4:01 PM Immunomedics Announces Fiscal 2009 Results - GlobeNewswire
1:07 AM UCB and Immunomedics announce positive results for epratuzumab phase IIb study in systemic lupus erythematosus (SLE) - Marketwire
1:00 AM UCB and Immunomedics Announce Positive Results for Epratuzumab Phase IIb Study in Systemic Lupus Erythematosus (SLE) - GlobeNewswire
Fri, Aug 14, 2009
8:31 AM Immunomedics Announces FDA Allowance of Investigational New Drug Application for Milatuzumab-Doxorubicin Conjugate - GlobeNewswire
Mon, Aug 03, 2009
6:51 AM StockPreacher.com Issues Trading Outlook for Hard to Treat Diseases Inc. - GlobeNewswire
Fri, Jul 24, 2009
8:30 AM Immunomedics Partners With Alexis Biotech to Develop Targeted Vaccines in Cancer and AIDS - GlobeNewswire
Tue, Jul 21, 2009
8:30 AM Immunomedics Announces U.S. Patent for a Facile Method of Fluorine-18 Labeling of Proteins and Peptides - GlobeNewswire
Wed, Jul 15, 2009
10:58 AM Immunomedics Announces U.S. Patents Awarded for Bispecific Antibody Technologies - GlobeNewswire
Wed, Jun 17, 2009
8:30 AM Immunomedics Reports Improved Efficacy With Combination Veltuzumab and Pretargeted Anti-CD20 Radioimmunotherapy in Lymphoma Model - GlobeNewswire
Tue, Jun 16, 2009
9:45 AM Immunomedics Reports New Antibody for Pretargeted Imaging and Therapy of Colorectal Cancer - GlobeNewswire
Mon, Jun 15, 2009
12:42 PM Immunomedics Reports Improved F-18 Labeling of Peptides for PET Imaging of Tumors - GlobeNewswire
8:30 AM Immunomedics Reports Updated Phase II Results With Radiolabeled Epratuzumab in Non-Hodgkin's Lymphoma - GlobeNewswire
Mon, Jun 08, 2009
8:30 AM Immunomedics to Present At the Society of Nuclear Medicine 56th Annual Meeting - GlobeNewswire
  Page 1 of 7   Next Page

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMediaTerms of Use. 
   
 
Home > Companies > Immunomedics, Inc